These results indicate that MeCP2 may regulate pathways implicated in AD pathogenesis, and the dysregulated de-novo patterns of striatal MeCP2 genomic occupancy during the early ages of APP/PS1 mice may contribute to various molecular changes in the early AD phenotypes. This evidence concerns the gene PSEN1 and Alzheimer disease.